FELL-HD
A trial to look at how different doses of felodipine are tolerated in people with early-stage Huntington’s disease
Phase 2 study testing felodipine to assess its safety and tolerability in people with Huntington's disease.
Recruitment endedPhase IINot specifiedISRCTNTreatment trial
Recruiting in: United Kingdom
Sponsor: Cambridge Clinical Trials Unit
Preparing a short plain-English summary.